Lung Cancer International

Volume 2013 (2013), Article ID 789057, 7 pages

http://dx.doi.org/10.1155/2013/789057

Research Article

Attitudes towards Lung Cancer Screening in an Australian High-Risk Population

Alexandra E. Flynn, Matthew J. Peters, and Lucy C. Morgan

Department of Thoracic Medicine, Concord Hospital, Hospital Road, Concord, NSW 2139, Australia

Received 31 January 2013; Accepted 17 June 2013

Academic Editor: Ladislav Tomasek

Copyright © 2013 Alexandra E. Flynn et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Objectives. To determine whether persons at high risk of lung cancer would participate in lung cancer screening test if available in Australia and to elicit general attitudes towards cancer screening and factors that might affect participation in a screening program. Methods. We developed a 20-item written questionnaire, based on two published telephone interview scripts, addressing attitudes towards cancer screening, perceived risk of lung cancer, and willingness to be screened for lung cancer and to undertake surgery if lung cancer were detected. The questionnaire was given to 102 current and former smokers attending the respiratory clinic and pulmonary rehabilitation programmes. Results. We gained 90 eligible responses (M:F, 69:21). Mean [SD] age was 63 and smoking history was 32 pack years. 95% of subjects would participate in a lung cancer screening test, and 91% of these would consider surgery if lung cancer was detected. 44% of subjects considered that they were at risk of lung cancer. This was lower in ex-smokers than in current smokers. Conclusions. There is high willingness for lung cancer screening and surgical treatment. There is underrecognition of risk among ex-smokers. This misperception could be a barrier to a successful screening or case-finding programme in Australia.

1. Introduction

There is considerable interest in the potential of lung cancer screening using low-dose CT scans to detect nodules that might be lung cancer early, at a treatable time point. Annual spiral CT screening detects lung cancers that are curable [1]. Whilst smaller randomised studies have not shown reduction in mortality, the largest performed to date, the US National Lung Cancer Screening Trial (NLST), showed reduction in both lung cancer specific and total mortalities [2] and has led to recommendations in favour of screening in the USA [3]. If these data are confirmed with other studies presently in progress, the case for CT screening implementation will further strengthen.

These programs are perhaps more aptly called case detection, rather than screening, as the intervention is targeted at individuals at high risk. The key factors that were used to select patients for inclusion in the research screening programs were age and cumulative smoking history with prolonged period since smoking cessation as an exclusion criterion [2, 4]. Inclusion criteria could be further refined in order to limit the number of subjects screened and increase the rate of cancer detection. The effectiveness of screening will be highly dependent on personal risk recognition by those in the target group.

Other factors that have been used to identify a screened population at higher risk include family history of cancer, asbestos exposure, or previous pneumonia [5]. Abnormal lung function and chronic cough are risk factors for lung cancer independent of smoking history [6, 7]. Abnormal spirometry and CT-diagnosed emphysema both increase the likelihood of lung cancer detection in a screening program [8]. Only lack of data for lung function in the large screened populations prevents the inclusion of lung function in deployed algorithms. Large multimodality screening programs tend to recruit healthier volunteers [9], and this may not be desirable for efficient lung cancer screening. An efficient screening program will attract and include those at the highest risk of lung cancer without severe comorbidities that would preclude curative treatment.

Australia has been successful in dramatically reducing the prevalence of smoking with adult smoking rates now around 16% [10] with a comprehensive approach including mass media campaigns that have highlighted tobacco use as a cause of lung cancer and do increase quit attempts [11]. Lung cancer remains the commonest cause of cancer mortality in both men and women [12], but a recent community survey found that this was not understood, and other cancers including breast cancer, prostate cancer, and skin cancer were thought to be more common causes of cancer death [13].

We reasoned that patients with smoking-related lung disease who attend a teaching hospital would have many of the defining characteristics for lung cancer risk. The aim of this study, therefore, was to explore attitudes of that group towards screening for lung cancer.

2. Methods

2.1. Development of Questionnaire

We developed a 20-item written questionnaire (see the Appendix) based in large part on two published telephone interview scripts. From a telephone survey in the USA conducted by Silvestri et al. (with permission) [14], we adapted nine questions about age, gender, general health, previous cancer, and cigarette smoking from a telephone interview format into written tick-box items. We also included four yes/no questions from the telephone interview about each subject’s perceived risk of lung cancer: whether a doctor had ever told them that they were at high risk for lung cancer, whether they would consider having a CT scan to determine the presence of lung cancer, and whether they would consider surgery for treatment.

From an Australian survey by Livingston et al. (with permission) [15], we used three questions that relate to perceptions about the benefits of early detection on life expectancy and treatment options [7]. We added one question to determine participation in other cancer screening programs and three new questions to determine whether test accuracy or the cost of a screening test would affect participation.

2.2. Subjects

In order to identify subjects at high lung cancer risk, we recruited a convenience sample of patients who were attending the Department of Respiratory Medicine at Concord Hospital or who were participating in the Pulmonary Rehabilitation program. In order to maximise participation, we sought to make the process as simple as possible, and subjects were given the option of self-completion of the questionnaire, home completion and return by post, or completion by telephone.

All subjects provided informed consent for participation, and the study was approved by the Concord Hospital Institutional Ethics Committee.

3. Results

3.1. Demographics and Background

Completed questionnaires were available for analysis from 91/102 subjects who agreed to participate and were provided a questionnaire. Data from one subject were excluded because of a previous lung cancer diagnosis. 69 subjects were male. Average age [SD] was 68 years with an average cumulative smoking history of 43 pack years. 22% were current smokers. Self-rated health status of the group, prevalence of previous cancers, and participation in other screening tests are shown in Table 1. 75% of women had undergone screening mammography, and 47% of men reported screening for prostate cancer.

Table 1: Subject characteristics.

Health rating
Excellent
Very good
Good
Fair
Poor
Blank

2
13
34
32
8
1

Previous cancer
None
Skin alone
Bowel/prostate
Breast/cervical
≥2 cancers
Blank

71
10
5
0
4
1

Screening tests for cancers
Male: ≥2 tests
Male: one test
Male: none
Female: ≥2 tests
Female: one test
Female: none

25
17
27
15
2
4

3.2. Attitudes towards the Early Detection of Cancer

A substantial majority of subjects believed that the early detection of cancer saves lives always or most of the time and that early detection of cancer enabled more effective treatment for lung cancer. Almost all subjects indicated that the chance of surviving would be higher if lung cancer were detected at an early stage (Table 2).

Table 2: Attitudes towards the early detection of cancer.

General beliefs
Respondents (%)

How often would early detection of cancer save lives?

    Never/some of the time
15

    Most of the time
39

    Always/all of the time
30

    Don’t know
6

How often does finding cancer early mean that a person can have more effective treatment?

    Never/some of the time
10

    Most of the time
35

    Always/all of the time
39

    Don’t know
6

Would a person’s chance of surviving be higher if lung cancer were detected at an early stage?

    Not at all higher
1

    Somewhat higher
20

    Very much higher
45

    Depends on person/type of cancer
13

    Don’t know
11

3.3. Recalled Information and Perceived Risk of Developing Lung Cancer

A minority of subjects in the whole group thought that they were at risk for lung cancer and even fewer recalled a doctor or another health professional telling them that they were at high risk of lung cancer (Table 3). Overall, former smokers were less likely than current smokers to consider themselves to be at risk for lung cancer (P < 0.002 for chi-squared test), and the perceived risk was lower for exsmokers at all smoking intensities. Amongst those subjects with a greater than 20 pack-year history of smoking, who might be a screening target group, half thought that they were at high risk of lung cancer and a third remembered a doctor telling them that they were at high risk.

Table 3

Subjects who believe that they are at risk for lung cancer

Former smokers
Current smokers

<20 pack years
21%
50%

20–40 pack years
30%
83%

40–60 pack years
28%
71%

>60 pack years
55%
100%

Any smoking history
34%
75%

Aged 55–74
29%
72%

Total group ()
43%

Has a doctor ever told you that you are at high risk for lung cancer?

Total group ()

29%

>20 pack years ()

33%

Former smokers ()

25%

Current smokers ()

40%

3.4. Willingness to Undergo Screening and Intervention

There was a high level of willingness to participate in screening (Table 4). All of the four subjects who would not undergo lung cancer screening were current smokers. Test accuracy at two levels had a relatively small effect on intent to participate, and a cost of A$250 (UK £160, 200) was not a barrier for the great majority of those who expressed a willingness to undergo screening. Almost all subjects would have lung cancer surgery if offered for a screen-detected tumour.

Table 4: Willingness to undergo screening.

Yes
No
Blank

Would you consider having this scan done to determine the presence of lung cancer?
86
4
0

    If the scan was 90% accurate
83
2
1

    If this scan was 70% accurate
71
12
3

    If you had to pay $250 to have the scan
69
16
1

    Would you have surgery for treatment? (subjects who would undergo scanning)
78
6
2

4. Discussion

If the data from the NLST are confirmed, CT-based screening or case detection could have a significant impact on mortality in those at increased risk of lung cancer. There are many preconditions beyond agreement that an effect exists and that modelling for cost effectiveness is favourable. One such precondition is that the target group, once defined, will recognise their risk situation and attend for screening. These data raise important questions about perception of risk in the target group whilst confirming that beliefs in the value of screening and expressed willingness to participate are generally high.

As interest develops in refining the ideal population for lung cancer case detection, it is important to focus first on the attitudes of those at the greatest risk of lung cancer and the greatest potential benefit. This study was not designed as a whole population sampling study but was conducted in such a population deliberately enriched for lung cancer risk. The difference in attitudes between this population and a more random population sample is uncertain. However, the quality of these data is enhanced by very high participation rate that was, we believe, a product of the study’s simplicity. Requiring additional procedures such as current lung function testing may have yielded more data at the expense of participation.

The average age of subjects, 68, is less than that for lung cancer currently diagnosed in Australia [12]. The median age in the whole population is over 70. However, given that age can indirectly influence the feasibility of curative treatment and that the majority of subjects were in the NLST target age range, this should not compromise the data. Cumulative smoking history is high and similar to that seen in the large lung cancer screening studies [2]. There seems to be no issue with the belief in the value of screening and willingness to participate in lung cancer screening specifically. Complete participation could not be expected and is not seen in bowel cancer screening programs [16] or for mammography [17].

Compared to a more general population in the US study on which this survey was partly based, these subjects had stronger beliefs in the value of screening, are more willing to consider computed tomography screening for lung cancer, and are more likely to opt for surgery if a cancer is detected. This may reflect a true difference in community health beliefs compared to those of the USA but we cannot exclude that beliefs and attitudes of those in the wider community with lesser contact with teaching hospital are different.

We have not tested the desire for lung cancer screening in those at low risk of lung cancer, but this would be important. Based on the major lung cancer screening studies, low-intensity smokers, those who have quit smoking more than 15 years ago and those younger than 50 or 55, would be excluded, but some with those characteristics might wish to be screened. It is reasonable to assume that the detection rate will be lower, that the proportion of benign to malignant nodules requiring further investigation will be higher, and that the radiation risks will be greater, particularly if screening is extended to younger age groups.

Notwithstanding all the public information available, some current smokers and the majority of exsmokers, in contact with tertiary-level health care, do not identify themselves as being at high risk of lung cancer. This is not for want of information. In Australia, general health warnings on cigarette packs were introduced in 1973, text warnings specific to lung cancer were required since 1987, and graphic lung cancer images were incorporated into cigarette packs since 2006 [18]. This study preceded the implementation of plain packaging and enhanced graphic imagery on cigarette packs. In addition, there have been mass media counter advertising campaigns specifically highlighting lung cancer for 40 years with graphic TV advertisements since 1997.

Two factors may contribute to this low-risk assessment. The first is self-exemption. This is a common phenomenon in long-term smokers who underestimate the effect of smoking on lung cancer risk and/or identify illusory counter factors that they suppose to reduce their individual risk. Self-exemption may be factor in the judgment of the four current smokers who would decline screening. The second is an overestimation of the magnitude or immediacy of the benefit of smoking cessation on lung cancer risk. The effect of this combination is that the precise group we wish to target for lung cancer screening may not identify themselves as being at risk and therefore may not present for voluntary screening. If lung cancer screening is implemented, effective information campaigns will need to include the message that exsmokers remain at risk and require screening for up to 15 years.

This will create an immediate tension. The message that smoking causes lung cancer has been an important part of Australian tobacco control programs. Anecdotal feedback suggests that amongst the new graphic cigarette pack images in Australia, that of Bryan, dying of lung cancer, is one of the most impactful images amongst current smokers [19]. Smokers, who are currently quitting, because of a belief that lung cancer risk is rapidly or completely extinguished by smoking cessation, may have misplaced beliefs but benefit greatly. This benefit may be reduced or countered if lung cancer screening program information campaign, that correctly states that an ex-smoker remains at high risk for some time after cessation, is implemented.

A majority of this group had not been told or did not recall being told by a doctor that they are at risk of lung cancer. It is possible that knowledge of health harm of smoking had been assumed. Alternatively, positive messaging in relation to smoking cessation may have been used to encourage cessation. More complex messaging from health professionals who do talk about smoking and lung cancer will face the same conundrum as that from mass media.

In summary, current and past smokers, in Australia, are willing to undergo lung cancer screening and subsequent treatment. However, the majority who are at high risk of lung cancer do not identify themselves as being at risk. They represent part of the optimal target group for lung cancer screening. Novel and effective education programs targeting this group will be necessary for optimal delivery of a lung cancer screening program, but these will have to be sympathetic with messaging in current antismoking campaigns.

Appendix

Questionnaire

(1) What is your age? … years old(2) Gender—Male/Female    □Male    □Female(3) In general, compared to other people your age, would you say that your health is    □Excellent    □Very Good    □Good    □Fair    □Poor(4) Has a doctor ever told you that you have had any cancer?     □Yes    □No(5) If you have had cancer, what kind of cancer? (tick all relevant boxes)    □None    □Lung cancer    □Breast cancer    □Bowel cancer    □Skin cancer    □Prostate cancer    □Cervical cancer    □Other(6) Have you smoked over 100 cigarettes in your life?    □Yes    □No(7) Do you currently smoke cigarettes?    □Yes    □No(8) For current smokers—On average how many cigarettes do you smoke per day? For former smokers—On average how many cigarettes did you smoke per day?    □0–9 cigarettes    □10–19    □20–29    □30–39    □40+ cigarettes(9) For current smokers—For how many years have you smoked this amount? For former smokers—For how many years did you smoke this amount?    □0–9 yrs    □10–19 yrs    □20–29 yrs    □30–39 yrs    □40–49 yrs    □50+ yrs(10) Have you ever had a screening test for any cancers? (tick all relevant boxes)    □Yes—breast cancer (mammogram)    □Yes—prostate cancer (blood test)    □Yes—cervical cancer (pap test)    □Yes—bowel cancer (stool sample)    □Yes—skin cancer (skin check)    □No(11) How often, would you say, that early detection of cancer saves lives?    □Always    □Most of the time    □Some of the time    □Never    □Don’t know(12) How often does finding cancer early mean that a person can have more effective treatment?    □Always    □Most of the time    □Some of the time    □Never    □Don’t know(13) Would a person’s chance of surviving be higher if lung cancer were detected at an early stage?    □Very much higher    □Somewhat higher    □Not at all higher    □Depends on the person/type of cancer    □Don’t know(14) Has a doctor or other health professional ever told you that you are at high risk for lung cancer?    □Yes    □No

Questions continued on next page

(15) Do you think that you are at risk for lung cancer?    □Yes    □No

A new low dose CAT scan has been developed which can find small cancers in the lung. If this scan finds cancer early, when it is small, the chances of curing the cancer is very high.

(16) If you were told that you were at risk for lung cancer, would you consider having this scan done to determine the presence of lung cancer?    □Yes    □No

The scan is not 100% accurate. Some small fast-growing cancers can be missed and some non-harmful benign nodules might be further investigated when they do not need to be.

(17) If the scan was 90% accurate would you consider having this scan done to determine the presence of lung cancer?    □Yes    □No(18) If the scan was 70% accurate would you consider having this scan done to determine the presence of lung cancer?    □Yes    □No(19) If you had to pay $250 to have the scan, would you consider having this scan done to determine the presence of lung cancer?    □Yes    □No(20) If this scan showed that you had lung cancer would you consider having surgery for treatment?    □Yes    □No

Authors’ Contribution

Alexandra E. Flynn did questionnaire design, data gathering and analysis, and drafting of the paper; Matthew J. Peters and Lucy C. Morgan made questionnaire review, data analysis, and paper review.

Conflict of Interests

The authors declare no conflict of interests.

Acknowledgments

The authors are grateful for the investigators who allowed them to incorporate part of their questionnaires into their own.

References

C. I. Henschke, D. F. Yankelevitz, D. M. Libby, M. W. Pasmantier, J. P. Smith, and O. S. Miettinen, “Survival of patients with stage I lung cancer detected on CT screening,” The New England Journal of Medicine, vol. 355, no. 17, pp. 1763–1771, 2006.

The National Lung Cancer Screening Trial Research team, “Reduced lung-cancer mortality with low-dose computed tomographic screening,” The New England Journal of Medicine, vol. 365, pp. 395–409, 2011.

R. Wender, E. T. H. Fontham, E. Barrera, et al., “American Cancer Society lung cancer screening guidelines,” Cancer Journal for Clinicians, vol. 63, no. 2, pp. 106–117, 2013.

C. A. van Iersel, H. J. de Koning, G. Draisma et al., “Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON),” International Journal of Cancer, vol. 120, no. 4, pp. 868–874, 2007.

O. Y. Raji, S. W. Duffy, O. F. Agbaje et al., “Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study,” Annals of Internal Medicine, vol. 157, pp. 242–250, 2012.

S. S. Islam and D. Schottenfeld, “Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan,” Cancer Epidemiology Biomarkers and Prevention, vol. 3, no. 4, pp. 289–298, 1994.

D. M. Mannino, S. M. Aguayo, T. L. Petty, and S. C. Redd, “Low lung function and incident lung cancer in the United States: data from the First National Health and Nutrition Examination Survey follow-up,” Archives of Internal Medicine, vol. 163, no. 12, pp. 1475–1480, 2003.

D. O. Wilson, J. L. Weissfeld, A. Balkan et al., “Association of radiographic emphysema and airflow obstruction with lung cancer,” The American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 7, pp. 738–744, 2008.

P. F. Pinsky, A. Miller, B. S. Kramer et al., “Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial,” The American Journal of Epidemiology, vol. 165, no. 8, pp. 874–881, 2007.

Australian Bureau of Statistics, “Australian health survey: first results,” Tobacco Smoking, 2011, http://www.abs.gov.au/ausstats/abs@.nsf/mf/4364.0.55.001

R. Borland and J. Balmford, “Understanding how mass media campaigns impact on smokers,” Tobacco Control, vol. 12, pp. ii45–ii52, 2003.

Australian Institute of Health and Welfare & Australasian Association of Cancer Registries, Cancer in Australia: An Overview, 2012, Cancer series no. 74. Cat. no. CAN 70, AIHW, Canberra, Australia, 2012.

Global Lung Cancer Coalition, Perceptions of lung cancer in Australia. An Ipsos MORI report for the Global Lung Cancer Coalition, http://lungcancercoalition.org/global-perceptions-lung-cancer

G. A. Silvestri, P. J. Nietert, J. Zoller, C. Carter, and D. Bradford, “Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts,” Thorax, vol. 62, no. 2, pp. 126–130, 2007.

P. Livingston, M. Wakefield, and J. M. Elwood, “Community attitudes towards the early detection of cancer in Victoria, Australia,” Australian and New Zealand Journal of Public Health, vol. 31, no. 1, pp. 26–29, 2007.

S. Javanparast, P. R. Ward, S. Cole et al., “A cross-sectional analysis of participation in National Bowel Cancer Screening Program in Adelaide by age, gender and geographical location of residence,” Australasian Medical Journal, vol. 1, no. 1, pp. 141–146, 2010.

Australian Institute of Health and Welfare, Breast Screen Australia Achievement Report, 1997 and 1998, Australian Institute of Health and Welfare, Canberra, Australia, 2000.

M. M. Scollo and M. H. Winstanley, “Tobacco in Australia: Facts and Issues,” 3rd Edition, Cancer Council Victoria, Melbourne, VIC, Australia, 2008, http://www.tobaccoinaustralia.org.au/

M. Koziol, “Warning: images may harm your smoking pleasure,” http://www.smh.com.au/national/health/warning-images-may-harm-your-smoking-pleasure-20121207-2b0v3.html